Cargando…

Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT

Cisplatin (Cis-DDP) is one of the most widely used anti-cancer drugs. It is applicable to many types of cancer, including lung, bladder, and breast cancer. However, its use is now limited because of drug resistance. p90 ribosomal S6 kinase (p90RSK) is one of the downstream effectors in the extracell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yujin, Huynh, Diem Thi Ngoc, Kang, Keon Wook, Myung, Chang-Seon, Heo, Kyung-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941763/ https://www.ncbi.nlm.nih.gov/pubmed/31818359 http://dx.doi.org/10.5483/BMBRep.2019.52.12.234

Ejemplares similares

Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway
por: Huynh, Diem Thi Ngoc, et al.
Publicado: (2022)

Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells
por: Jin, Yujin, et al.
Publicado: (2021)

Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death through ROS-Mediated Akt Signaling
por: Huynh, Diem Thi Ngoc, et al.
Publicado: (2021)

Role of p90RSK in Kidney and Other Diseases
por: Lin, Ling, et al.
Publicado: (2019)

Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway
por: Lee, Cheol-Jung, et al.
Publicado: (2015)

Radiation therapy induces immunosenescence mediated by p90RSK
por: Imanishi, Masaki, et al.
Publicado: (2022)

Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages
por: Huynh, Diem Thi Ngoc, et al.
Publicado: (2020)

p90Rsk is not involved in cytostatic factor arrest in mouse oocytes
por: Dumont, Julien, et al.
Publicado: (2005)

Hsp90 inhibition sensitizes DLBCL cells to cisplatin
por: Schmidt, Linnéa, et al.
Publicado: (2022)

RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer
por: Cuesta, Rafael, et al.
Publicado: (2016)

Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima
por: Hwang, Ae-Rang, et al.
Publicado: (2023)

p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration
por: Samson, Shiela C., et al.
Publicado: (2019)

P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation
por: Li, Ping, et al.
Publicado: (2012)

FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells
por: Han, Jung-Hwa, et al.
Publicado: (2019)

The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility
por: Artamonov, Mykhaylo, et al.
Publicado: (2013)

The p90rsk-mediated signaling of ethanol-induced cell proliferation in HepG2 cell line
por: Kim, Han Sang, et al.
Publicado: (2016)

Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK)
por: Lucien, Fabrice, et al.
Publicado: (2011)

Luteolin suppresses UVB-induced photoageing by targeting JNK1 and p90(RSK2)
por: Lim, Sung H, et al.
Publicado: (2013)

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors
por: Maietta, Immacolata, et al.
Publicado: (2022)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 Phosphorylation
por: Vu, Hang Thi, et al.
Publicado: (2018)

Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
por: Moon, Hyeong-Gon, et al.
Publicado: (2012)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process
por: Shi, Chunling, et al.
Publicado: (2021)

PDCD10 promotes proliferation, migration, and invasion of osteosarcoma by inhibiting apoptosis and activating EMT pathway
por: Xu, Ke, et al.
Publicado: (2022)

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
por: Chae, Hee-Don, et al.
Publicado: (2020)

rSK1 in Rat Neurons: A Controller of Membrane rSK2?
por: Autuori, Eleonora, et al.
Publicado: (2019)

EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models
por: Guo, Yanru, et al.
Publicado: (2023)

IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells
por: Widjaja, Anissa A., et al.
Publicado: (2022)

Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity
por: Xifró, Xavier, et al.
Publicado: (2011)

Fibroblast p90RSK induces epithelial transdifferentiation through oxidative stress‐mediated β‐catenin pathway
por: Shi, Chaowen, et al.
Publicado: (2023)

microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1
por: Cao, Riliang, et al.
Publicado: (2018)

miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3
por: Wang, Guojun, et al.
Publicado: (2017)

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer
por: Yang, Won Seok, et al.
Publicado: (2023)

Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process
por: Ma, Hongxin, et al.
Publicado: (2019)

Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1
por: Wei, Chunli, et al.
Publicado: (2022)

LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process
por: Liu, Linjun, et al.
Publicado: (2023)

MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3–phospho-BAD pathway
por: Guan, Xiaolin, et al.
Publicado: (2022)

Correction to: microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1
por: Cao, Riliang, et al.
Publicado: (2021)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f9v7215vr6n9il0ic5leg6r6j0